SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-012441
Filing Date
2021-04-12
Accepted
2021-04-12 16:20:28
Documents
1
Period of Report
2021-04-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K brhc10022887_8k.htm 8-K 15028
  Complete submission text file 0001140361-21-012441.txt   16309
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 21820958
SIC: 2834 Pharmaceutical Preparations